Search

Joseph A Kaufman

Examiner (ID: 10129)

Most Active Art Unit
3754
Art Unit(s)
3752, 3993, 3727, 3754, 3108, 3104
Total Applications
1964
Issued Applications
1543
Pending Applications
181
Abandoned Applications
196

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5619364 [patent_doc_number] => 20060188897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Transposon mediated differential hybridisation' [patent_app_type] => utility [patent_app_number] => 11/220910 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11600 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188897.pdf [firstpage_image] =>[orig_patent_app_number] => 11220910 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/220910
Transposon mediated differential hybridisation Sep 7, 2005 Abandoned
Array ( [id] => 5648335 [patent_doc_number] => 20060134067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Loading of cells with antigens by electroporation' [patent_app_type] => utility [patent_app_number] => 11/219307 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19992 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134067.pdf [firstpage_image] =>[orig_patent_app_number] => 11219307 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/219307
Loading of cells with antigens by electroporation Sep 1, 2005 Abandoned
Array ( [id] => 5828217 [patent_doc_number] => 20060063260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Method for producing a support carrying immobilized viruses, and the use of such a support' [patent_app_type] => utility [patent_app_number] => 11/219122 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7157 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063260.pdf [firstpage_image] =>[orig_patent_app_number] => 11219122 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/219122
Method for producing a support carrying immobilized viruses, and the use of such a support Sep 1, 2005 Abandoned
Array ( [id] => 5760062 [patent_doc_number] => 20060211007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Ligand/binding partner bio-labeling systems' [patent_app_type] => utility [patent_app_number] => 11/219506 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8434 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211007.pdf [firstpage_image] =>[orig_patent_app_number] => 11219506 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/219506
Ligand/binding partner bio-labeling systems Aug 31, 2005 Issued
Array ( [id] => 5165313 [patent_doc_number] => 20070286898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Intracellular Drug Delivery Improving Liposome' [patent_app_type] => utility [patent_app_number] => 11/661431 [patent_app_country] => US [patent_app_date] => 2005-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5029 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20070286898.pdf [firstpage_image] =>[orig_patent_app_number] => 11661431 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/661431
Intracellular Drug Delivery Improving Liposome Aug 29, 2005 Abandoned
Array ( [id] => 5618946 [patent_doc_number] => 20060188479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Adenovirus vectors containing cell status-specific response elements and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/206135 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16177 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188479.pdf [firstpage_image] =>[orig_patent_app_number] => 11206135 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/206135
Adenovirus vectors containing cell status-specific response elements and methods of use thereof Aug 17, 2005 Abandoned
Array ( [id] => 5813935 [patent_doc_number] => 20060084093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins' [patent_app_type] => utility [patent_app_number] => 11/204755 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 6403 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084093.pdf [firstpage_image] =>[orig_patent_app_number] => 11204755 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/204755
Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins Aug 15, 2005 Abandoned
Array ( [id] => 7250338 [patent_doc_number] => 20050272685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Intraductal treatment targeting methylated promoters in breast cancer' [patent_app_type] => utility [patent_app_number] => 11/203800 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1614 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272685.pdf [firstpage_image] =>[orig_patent_app_number] => 11203800 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/203800
Intraductal treatment targeting methylated promoters in breast cancer Aug 14, 2005 Abandoned
Array ( [id] => 5609104 [patent_doc_number] => 20060270620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Method of Enhancing Therapeutic Effect of Nucleic Acids' [patent_app_type] => utility [patent_app_number] => 11/161665 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3472 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270620.pdf [firstpage_image] =>[orig_patent_app_number] => 11161665 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/161665
Method of Enhancing Therapeutic Effect of Nucleic Acids Aug 10, 2005 Abandoned
Array ( [id] => 4644251 [patent_doc_number] => 08021856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity' [patent_app_type] => utility [patent_app_number] => 11/199232 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 14637 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/021/08021856.pdf [firstpage_image] =>[orig_patent_app_number] => 11199232 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/199232
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity Aug 8, 2005 Issued
Array ( [id] => 4644251 [patent_doc_number] => 08021856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity' [patent_app_type] => utility [patent_app_number] => 11/199232 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 14637 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/021/08021856.pdf [firstpage_image] =>[orig_patent_app_number] => 11199232 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/199232
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity Aug 8, 2005 Issued
Array ( [id] => 4501816 [patent_doc_number] => 07919583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Integration-site directed vector systems' [patent_app_type] => utility [patent_app_number] => 11/198987 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 11 [patent_no_of_words] => 15111 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919583.pdf [firstpage_image] =>[orig_patent_app_number] => 11198987 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198987
Integration-site directed vector systems Aug 7, 2005 Issued
Array ( [id] => 9113192 [patent_doc_number] => 08569365 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Compositions and methods for controlling infections' [patent_app_type] => utility [patent_app_number] => 11/195239 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7760 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11195239 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/195239
Compositions and methods for controlling infections Aug 1, 2005 Issued
Array ( [id] => 9113192 [patent_doc_number] => 08569365 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Compositions and methods for controlling infections' [patent_app_type] => utility [patent_app_number] => 11/195239 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7760 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11195239 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/195239
Compositions and methods for controlling infections Aug 1, 2005 Issued
Array ( [id] => 9113192 [patent_doc_number] => 08569365 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Compositions and methods for controlling infections' [patent_app_type] => utility [patent_app_number] => 11/195239 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7760 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11195239 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/195239
Compositions and methods for controlling infections Aug 1, 2005 Issued
Array ( [id] => 9113192 [patent_doc_number] => 08569365 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Compositions and methods for controlling infections' [patent_app_type] => utility [patent_app_number] => 11/195239 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7760 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11195239 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/195239
Compositions and methods for controlling infections Aug 1, 2005 Issued
Array ( [id] => 5769060 [patent_doc_number] => 20060019897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Anti-angiogenic polypeptides' [patent_app_type] => utility [patent_app_number] => 11/188576 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7500 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019897.pdf [firstpage_image] =>[orig_patent_app_number] => 11188576 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/188576
Anti-angiogenic polypeptides Jul 24, 2005 Abandoned
Array ( [id] => 5888639 [patent_doc_number] => 20060275781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Novel method for the protection and purification of adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 11/187319 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30514 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275781.pdf [firstpage_image] =>[orig_patent_app_number] => 11187319 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/187319
Novel method for the protection and purification of adenoviral vectors Jul 21, 2005 Abandoned
Array ( [id] => 7227882 [patent_doc_number] => 20050255462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Compounds displayed on replicable genetic packages and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/187989 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 35805 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255462.pdf [firstpage_image] =>[orig_patent_app_number] => 11187989 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/187989
Compounds displayed on replicable genetic packages and methods of using same Jul 21, 2005 Issued
Array ( [id] => 9676654 [patent_doc_number] => 08815563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Modified virus' [patent_app_type] => utility [patent_app_number] => 11/572556 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 13589 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11572556 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/572556
Modified virus Jul 17, 2005 Issued
Menu